New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia

Clinical Interventions in Aging

Volumn 7, Issue , 2012, Pages 393-396

  Kung, Fan Chin ^a   Ishii, Ryouhei ^b   Liu, Hsing Cheng ^c   Takeda, Masatoshi ^b  

^a Yuli Hospital   (Taiwan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Alzheimer's disease; Behavioral and psychological symptoms of dementia; Dementia; Glutamate; Kampo; Yokukansan

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; GLUTAMIC ACID; HERBACEOUS AGENT; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RIVASTIGMINE; UNCLASSIFIED DRUG; YOKUKANSAN;

AGITATION; ALZHEIMER DISEASE; BEHAVIOR DISORDER; BEHAVIORAL AND PSYCHIATRIC SYMPTOM OF DEMENTIA; CHINESE MEDICINE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG APPROVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EXCITOTOXICITY; FRONTOTEMPORAL DEMENTIA; HEALTH INSURANCE; HUMAN; INSOMNIA; JAPAN; JAPANESE MEDICINE; LIFE EXPECTANCY; MEDICINAL PLANT; MENTAL DISEASE; MONOTHERAPY; MULTIINFARCT DEMENTIA; MYOCLONUS; PARKINSON DISEASE; PUBLIC HEALTH PROBLEM; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESSNESS; REVIEW; TRADITIONAL MEDICINE; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT;

BEHAVIORAL SYMPTOMS; DEMENTIA; DRUGS, CHINESE HERBAL; HUMANS; JAPAN; MEDICINE, CHINESE TRADITIONAL; MEDICINE, EAST ASIAN TRADITIONAL; MENTAL DISORDERS;

EID: 84872289238     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S36509     Document Type: Review

References (30)

1. Hwang JP, Yang CH, Tsai SJ, etal. Behavioral disturbances in psychiatric inpatients with dementia of the Alzheimer's type in Taiwan. Int J Geriatr Psychiatry. 1997;12(9):902-906.
2. Chow TW, Liu CK, Fuh JL, etal. Neuropsychiatric symptoms of Alzheimer's disease differ in Chinese and American patients. Int J Geriatr Psychiatry. 2002;17(1):22-28.
3. Fuh JL, Liu CY, Wang SJ, etal. Revised memory and behavior problems checklist in Taiwanese patients with Alzheimer's disease. Int Psychogeriatr. 1999;11(2):181-189.
4. Lawlor BA. Behavioural and psychological symptoms in dementia: the role of atypical antipsychotics. J Clin Psychiatry. 2004;65(11):5-10.
5. Mizukami K, Asada T, Kinoshita T, etal. A randomized cross-over study of traditional Japanese medicine (Kampo), yokukansan, in the treatment of behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol. 2009;12(2):191-199.
6. Lanari A, Amenta F, Silvestrelli G, Tomassoni D, Parnetti L. Neurotransmitter deficits in behavioral and psychological symptoms of Alzheimer's disease. Mech Ageing Dev. 2006;127(2):158-165.
7. Efficacy and adverse effects of atypical antipsychotics for dementia: meta analysis of randomised, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14(3):191-210.
8. Fuh JL, Wang SJ. Dementia in Taiwan: past, present, and future. Acta Neurol Taiwan. 2008;17(3):153-161.
9. Takeda M. Integration of drugs and non-pharmacological intervention to Alzheimer patients. Psychogeriatrics. 2012;12(1):1-2.
10. Iwasaki K, Satoh-Nakagawa T, Maruyama M, etal. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioural and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry. 2005;66(2):248-252.
11. de Caires S, Steenkamp V. Use of yokukansan (TJ-54) in the treatment of neurological disorders: a review. Phytother Res. 2010;24(9):1265-1270.
12. Okamoto H, Okami T, Ikeda M, Takeuchi T. Effects of yokukansan on undifferentiated somatoform disorder with tinnitus. Eur Psychiatry. 2004;20(1):74-75.
13. Takeda A, Itoh H, Tamano H, Yuzurihara M, Oku N. Suppressive effect of yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats. Nutr Neurosci. 2008;11(1):41-46.
14. Tateno M, Ukai W, Ono T, Saito S, Hashimoto E, Saito T. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons. Prog Neuropsychopharmacol. 2008;32(7):1704-1707.
15. Ishii K. Sleep disorders in the elderly and Kampo medicine. Kampo Newest Ther. 2000;9(1):21-26.
16. Aizawa R, Kanbayashi T, Saito Y, etal. Effects of Yoku-kansan-ka-chimpi-hange on the sleep of normal healthy adult subjects. Psychiatry Clin Neurosci. 2002;56(3):303-304.
17. Monji A, Takita M, Samejima T, etal. Effects of yokukansan on the behavioural and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol. 2009;33(2):308-311.
18. Okahara K, Ishida Y, Hayashi Y, etal. Effects of yokukansan on behavioral and psychological symptoms of dementia in regular treatment of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(3):532-536.
19. Shinno H, Inami Y, Inagaki T, etal. Effect of yi-gan san on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(3):881-885.
20. Shinno H, Utani E, Okazaki S, etal. Successful treatment with yi-gan san for psychosis and sleep disturbance in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(7):1543-1545.
21. Mizukami KA, Asada TA, Kinoshita TB, etal. A randomized cross-over study of a traditional Japanese medicine (Kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol. 2009;12(2):191-199.
22. Kimura T, Hayashida H, Furukawa H, etal. Five cases of frontotemporal dementia with behavioral symptoms improved by yokukansan. Psychogeriatrics. 2009;9(1):38-43.
23. Kawanabe T, Yoritaka A, Shimura H, etal. Successful treatment with yokukansan for behavioral and psychological symptoms of Parkinsonian dementia. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):284-287.
24. Nagata K, Yokoyama E, Yamazaki T, etal. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial. Phytomedicine. 2012;19(6):524-528.
25. Egashira N, Iwasaki K, Ishibashi A, etal. Repeated administration of yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT) 2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(6):1516-1520.
26. Ito T. Regulatory effects of yoku-kan-san-ka-chimpi-hange and saiko-karyukotsu-borei-to on function of the central nervous system in mice. Prog Med. 1997;17:823-830.
27. Yabe T, Torizuka K, Yamada H. Effects of Kampo medicines on choline acetyltransferase activity in rat embryo septal cultures. J Trad Med. 1995;12:54-60.
28. Tabuchi M, Yamaguchi T, Iizuka S, Imamura S. Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576mouse model of Alzheimer's disease. J Ethnopharmacol. 2009;122(1):157-162.
29. Kawakami Z, Kanno H, Ueki T, et al. Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells. Neuroscience. 2009;159(4):1397-1407.
30. Shih SF, Lew-Ting CY, Chang HY, Kuo KN. Insurance covered and non-covered complementary and alternative medicine utilization among adults in Taiwan. Soc Sci Med. 2008;67(7):1183-1189.